From the genetics of ankylosing spondylitis to new biology and drug target discovery
Genome-wide association studies (GWAS) have identified 113 single nucleotide polymorphisms (SNPs) affecting the risk of developing ankylosing spondylitis (AS), and an on-going GWAS study will likely identify 100+ new risk loci. The translation of genetic findings to novel disease biology and treatme...
Κύριοι συγγραφείς: | Zaarour, N, Li, Y, Shi, H, Bowness, P, Chen, L |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
Frontiers Media
2021
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
OVERVIEW OF ANKYLOSING SPONDYLITIS GENETICS AND PATHOGENESIS
ανά: Bowness, P
Έκδοση: (2012) -
GM-CSF primes proinflammatory monocyte responses in Ankylosing Spondylitis
ανά: Shi, H, κ.ά.
Έκδοση: (2020) -
The immunology of Ankylosing Spondylitis
ανά: Bowness, P
Έκδοση: (2011) -
New developments in our understanding of Ankylosing Spondylitis pathogenesis
ανά: Voruganti, A, κ.ά.
Έκδοση: (2020) -
Discovery of candidate serum proteomic and metabolomic biomarkers in ankylosing spondylitis.
ανά: Fischer, R, κ.ά.
Έκδοση: (2012)